Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
how often is not established Adults with obesity (BMI 30) or with overweight (BMI 27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
The compound is not approved by any regulatory authority, and its safety or effectiveness in humans has not been established
Tipo de Producto Antiobesidad Laboratorio Laboratorios Liomont SA de CV
